TAK 259
Catalog No. A16186
TAK-259是一种新型的，选择性的，口服活性的α1D肾上腺素受体拮抗剂（α1D，Ki = 1.1 nM），具有抗尿频效应并减少人类以太相关基因（hERG）的责任。
| Catalog Num | A16186 |
|---|---|
| M. Wt | 410.7 |
| Formula | C14H14Cl3N3O3S |
| Purity | >98% |
| Storage | at -20°C 3 years Powder |
| CAS No. | 1192347-42-4 |
| Synonyms | TAK259, TAK-259 |
| SMILES | O=C(C1=CC(Cl)=CN(CC2=CC(Cl)=CC=C2S(=O)(C)=O)C1=N)N.[H]Cl |
TAK-259是一种新型的，选择性的，口服活性的α1D肾上腺素受体拮抗剂（α1D，Ki = 1.1 nM），具有抗尿频效应并减少人类以太相关基因（hERG）的责任。
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 0.1 mM | 24.35 mL | 121.74 mL | 243.49 mL |
| 0.5 mM | 4.87 mL | 24.35 mL | 48.7 mL |
| 1 mM | 2.43 mL | 12.17 mL | 24.35 mL |
| 5 mM | 0.49 mL | 2.43 mL | 4.87 mL |
*The above data is based on the productmolecular weight 410.7. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
Contact information
United StatesAdooq Bioscience
Toll Free: (866) 930-6790
Fax: +1-323-606-8156
Email: sales@adooq.com
ADOOQ 产品质量保证
We promise all products to perform as described.